Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
Alice M JacksonPardeep S JhundInder S AnandHans-Dirk DüngenCarolyn S P LamMartin P LefkowitzGerard LinssenLars H LundAldo Pietro MaggioniMarc A PfefferJean L RouleauJosé Francisco Kerr SaraivaMichele SenniOrly VardenyMagnus Olof WijkmanMehmet Birhan YilmazYoshihiko SaitoMichael R ZileScott D SolomonJohn Joseph Valentine McMurrayPublished in: European heart journal (2021)
PARAGON-HF: ClinicalTrials.gov Identifier NCT01920711.